Home › Markets › Industrials › TXG

10x Genomics Inc. (TXG)

TXG trades on Nasdaq in Industrials, Biotechnology: Laboratory Analytical Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$71.79
-4.52% on the day
Market cap
$9.4B
Mid cap
Revenue · 2025
$642.8M
+5.2% on 2024
Net income · 2025
-$43.5M
-6.8% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.

Profile

FieldValue
TickerTXG on Nasdaq
SectorIndustrials
IndustryBiotechnology: Laboratory Analytical Instruments
CountryUnited States
IPO year2019
SEC CIK0001770787
SEC industry codeLaboratory Analytical Instruments
Incorporated inDE

Financials · 2025

LineValue
Revenue$642.8M
Net income-$43.5M
Operating income-$61.0M
Net margin-6.8%
Operating margin-9.5%
Revenue growth+5.2%
CashNot in SEC XBRL data
Total assets$1.0B
P/E (computed)Net income was not positive
P/S (computed)14.6×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-3ASR2020-10-16
Latest annual report10-K2026-02-13
Latest quarterly / interim10-Q2026-08-07
Latest current report8-K2026-08-06
Latest proxyDEFA14A2026-04-24

Source: SEC EDGAR submissions feed, 694 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-3.8%
1 month-1.6%
3 months+64.6%
Year to date+348.8%
1 year+531.1%
From 52-week high-25.1%

Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Laboratory Analytical Instruments

TickerCompanyPriceDayMarket cap
BIOBio-Rad Laboratories Inc.$363.73-0.19%$9.7B
BRKRBruker Corporation$56.19-0.11%$8.6B
AVTRAvantor Inc.$15.55+0.39%$10.5B
RVTYRevvity Inc.$155.08-0.34%$17.3B
MTDMettler-Toledo International Inc.$1598.03+2.24%$32.0B
WATWaters Corporation$429.17-0.68%$42.2B
AAgilent Technologies Inc.$171.60+0.16%$48.4B
ALMRAlamar Biosciences Inc.$23.52-2.97%$1.6B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier